CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia

Our study aimed to determine the expression pattern and clinical relevance of CD 99 in paediatric B‐cell precursor acute lymphoblastic leukaemia ( BCP ‐ ALL ). Our findings demonstrate that high expression levels of CD 99 are mainly found in high‐risk BCP ‐ ALL , e.g. BCR ‐ ABL 1 and CRLF 2 Re/Hi ,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2019-02, Vol.184 (3), p.418-423
Hauptverfasser: Chen, Dongfeng, Camponeschi, Alessandro, Wu, Qingqing, Gerasimcik, Natalija, Li, Huiqi, Shen, Xue, Tan, Yujie, Sjögren, Helene, Nordlund, Jessica, Lönnerholm, Gudmar, Abrahamsson, Jonas, Fogelstrand, Linda, Mårtensson, Inga‐Lill
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 423
container_issue 3
container_start_page 418
container_title British journal of haematology
container_volume 184
creator Chen, Dongfeng
Camponeschi, Alessandro
Wu, Qingqing
Gerasimcik, Natalija
Li, Huiqi
Shen, Xue
Tan, Yujie
Sjögren, Helene
Nordlund, Jessica
Lönnerholm, Gudmar
Abrahamsson, Jonas
Fogelstrand, Linda
Mårtensson, Inga‐Lill
description Our study aimed to determine the expression pattern and clinical relevance of CD 99 in paediatric B‐cell precursor acute lymphoblastic leukaemia ( BCP ‐ ALL ). Our findings demonstrate that high expression levels of CD 99 are mainly found in high‐risk BCP ‐ ALL , e.g. BCR ‐ ABL 1 and CRLF 2 Re/Hi , and that high CD 99 mRNA levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that CD 99 is a potential biomarker for BCP ‐ ALL .
doi_str_mv 10.1111/bjh.15683
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1111_bjh_15683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1111_bjh_15683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</originalsourceid><addsrcrecordid>eNotkL1OwzAUhS0EEqUw8AZ3ZUix48SxRyi_UiWW7pHj3BAXJ47sRNAJHoFn5EloKWc5y9EnnY-QS0YXbJfratMuWC4kPyIzxkWepCxjx2RGKS0SRjN5Ss5i3FDKOM3ZjHwu70ApwI8hYIzW92AjxDH4_tVtQcfojdUj1vBuxxaMs7012oGfRuM7BNuDaa2rA_aHxe3P17dB52DHM1OIPoA204jgtt3Q-srpOFoDDqc3jZ3V5-Sk0S7ixX_Pyfrhfr18SlYvj8_Lm1ViiowniFIqgbLALJUVT3VTMYFCCdHQAnOGmsoil41Smdi_NqKqNc-VqASt06zgc3J1wJrgYwzYlEOwnQ7bktFyL67ciSv_xPFfzhpjug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</title><source>Wiley Free Content</source><source>Wiley Online Library All Journals</source><creator>Chen, Dongfeng ; Camponeschi, Alessandro ; Wu, Qingqing ; Gerasimcik, Natalija ; Li, Huiqi ; Shen, Xue ; Tan, Yujie ; Sjögren, Helene ; Nordlund, Jessica ; Lönnerholm, Gudmar ; Abrahamsson, Jonas ; Fogelstrand, Linda ; Mårtensson, Inga‐Lill</creator><creatorcontrib>Chen, Dongfeng ; Camponeschi, Alessandro ; Wu, Qingqing ; Gerasimcik, Natalija ; Li, Huiqi ; Shen, Xue ; Tan, Yujie ; Sjögren, Helene ; Nordlund, Jessica ; Lönnerholm, Gudmar ; Abrahamsson, Jonas ; Fogelstrand, Linda ; Mårtensson, Inga‐Lill</creatorcontrib><description>Our study aimed to determine the expression pattern and clinical relevance of CD 99 in paediatric B‐cell precursor acute lymphoblastic leukaemia ( BCP ‐ ALL ). Our findings demonstrate that high expression levels of CD 99 are mainly found in high‐risk BCP ‐ ALL , e.g. BCR ‐ ABL 1 and CRLF 2 Re/Hi , and that high CD 99 mRNA levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that CD 99 is a potential biomarker for BCP ‐ ALL .</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.15683</identifier><language>eng</language><ispartof>British journal of haematology, 2019-02, Vol.184 (3), p.418-423</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</citedby><cites>FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</cites><orcidid>0000-0003-1910-1234</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids></links><search><creatorcontrib>Chen, Dongfeng</creatorcontrib><creatorcontrib>Camponeschi, Alessandro</creatorcontrib><creatorcontrib>Wu, Qingqing</creatorcontrib><creatorcontrib>Gerasimcik, Natalija</creatorcontrib><creatorcontrib>Li, Huiqi</creatorcontrib><creatorcontrib>Shen, Xue</creatorcontrib><creatorcontrib>Tan, Yujie</creatorcontrib><creatorcontrib>Sjögren, Helene</creatorcontrib><creatorcontrib>Nordlund, Jessica</creatorcontrib><creatorcontrib>Lönnerholm, Gudmar</creatorcontrib><creatorcontrib>Abrahamsson, Jonas</creatorcontrib><creatorcontrib>Fogelstrand, Linda</creatorcontrib><creatorcontrib>Mårtensson, Inga‐Lill</creatorcontrib><title>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</title><title>British journal of haematology</title><description>Our study aimed to determine the expression pattern and clinical relevance of CD 99 in paediatric B‐cell precursor acute lymphoblastic leukaemia ( BCP ‐ ALL ). Our findings demonstrate that high expression levels of CD 99 are mainly found in high‐risk BCP ‐ ALL , e.g. BCR ‐ ABL 1 and CRLF 2 Re/Hi , and that high CD 99 mRNA levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that CD 99 is a potential biomarker for BCP ‐ ALL .</description><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkL1OwzAUhS0EEqUw8AZ3ZUix48SxRyi_UiWW7pHj3BAXJ47sRNAJHoFn5EloKWc5y9EnnY-QS0YXbJfratMuWC4kPyIzxkWepCxjx2RGKS0SRjN5Ss5i3FDKOM3ZjHwu70ApwI8hYIzW92AjxDH4_tVtQcfojdUj1vBuxxaMs7012oGfRuM7BNuDaa2rA_aHxe3P17dB52DHM1OIPoA204jgtt3Q-srpOFoDDqc3jZ3V5-Sk0S7ixX_Pyfrhfr18SlYvj8_Lm1ViiowniFIqgbLALJUVT3VTMYFCCdHQAnOGmsoil41Smdi_NqKqNc-VqASt06zgc3J1wJrgYwzYlEOwnQ7bktFyL67ciSv_xPFfzhpjug</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Chen, Dongfeng</creator><creator>Camponeschi, Alessandro</creator><creator>Wu, Qingqing</creator><creator>Gerasimcik, Natalija</creator><creator>Li, Huiqi</creator><creator>Shen, Xue</creator><creator>Tan, Yujie</creator><creator>Sjögren, Helene</creator><creator>Nordlund, Jessica</creator><creator>Lönnerholm, Gudmar</creator><creator>Abrahamsson, Jonas</creator><creator>Fogelstrand, Linda</creator><creator>Mårtensson, Inga‐Lill</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-1910-1234</orcidid></search><sort><creationdate>201902</creationdate><title>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</title><author>Chen, Dongfeng ; Camponeschi, Alessandro ; Wu, Qingqing ; Gerasimcik, Natalija ; Li, Huiqi ; Shen, Xue ; Tan, Yujie ; Sjögren, Helene ; Nordlund, Jessica ; Lönnerholm, Gudmar ; Abrahamsson, Jonas ; Fogelstrand, Linda ; Mårtensson, Inga‐Lill</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Dongfeng</creatorcontrib><creatorcontrib>Camponeschi, Alessandro</creatorcontrib><creatorcontrib>Wu, Qingqing</creatorcontrib><creatorcontrib>Gerasimcik, Natalija</creatorcontrib><creatorcontrib>Li, Huiqi</creatorcontrib><creatorcontrib>Shen, Xue</creatorcontrib><creatorcontrib>Tan, Yujie</creatorcontrib><creatorcontrib>Sjögren, Helene</creatorcontrib><creatorcontrib>Nordlund, Jessica</creatorcontrib><creatorcontrib>Lönnerholm, Gudmar</creatorcontrib><creatorcontrib>Abrahamsson, Jonas</creatorcontrib><creatorcontrib>Fogelstrand, Linda</creatorcontrib><creatorcontrib>Mårtensson, Inga‐Lill</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Dongfeng</au><au>Camponeschi, Alessandro</au><au>Wu, Qingqing</au><au>Gerasimcik, Natalija</au><au>Li, Huiqi</au><au>Shen, Xue</au><au>Tan, Yujie</au><au>Sjögren, Helene</au><au>Nordlund, Jessica</au><au>Lönnerholm, Gudmar</au><au>Abrahamsson, Jonas</au><au>Fogelstrand, Linda</au><au>Mårtensson, Inga‐Lill</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</atitle><jtitle>British journal of haematology</jtitle><date>2019-02</date><risdate>2019</risdate><volume>184</volume><issue>3</issue><spage>418</spage><epage>423</epage><pages>418-423</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Our study aimed to determine the expression pattern and clinical relevance of CD 99 in paediatric B‐cell precursor acute lymphoblastic leukaemia ( BCP ‐ ALL ). Our findings demonstrate that high expression levels of CD 99 are mainly found in high‐risk BCP ‐ ALL , e.g. BCR ‐ ABL 1 and CRLF 2 Re/Hi , and that high CD 99 mRNA levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that CD 99 is a potential biomarker for BCP ‐ ALL .</abstract><doi>10.1111/bjh.15683</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1910-1234</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2019-02, Vol.184 (3), p.418-423
issn 0007-1048
1365-2141
language eng
recordid cdi_crossref_primary_10_1111_bjh_15683
source Wiley Free Content; Wiley Online Library All Journals
title CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A33%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD%2099%20expression%20is%20strongly%20associated%20with%20clinical%20outcome%20in%20children%20with%20B%E2%80%90cell%20precursor%20acute%20lymphoblastic%20leukaemia&rft.jtitle=British%20journal%20of%20haematology&rft.au=Chen,%20Dongfeng&rft.date=2019-02&rft.volume=184&rft.issue=3&rft.spage=418&rft.epage=423&rft.pages=418-423&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.15683&rft_dat=%3Ccrossref%3E10_1111_bjh_15683%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true